NVO news, real time NVO stock news, Novo-Nordisk A/S news today

News

NVO

47.64

+9.92%

4.30

Health Regulators Ask DOJ to Investigate Hims & Hers. The Stock Plunges.

Barron‘s · 4h ago

BUZZ-Hims & Hers down after FDA to restrict GLP-1 ingredients used in non-approved compounded drugs

Reuters · 7h ago

TrumpRx Is Here. Most People Won't Benefit.

Barron‘s · 8h ago

UPDATE 4-US signals crackdown on compounded weight-loss drugs; Hims shares tumble

Reuters · 8h ago

UPDATE 5-US signals crackdown on compounded weight-loss drugs; Hims shares tumble

Reuters · 8h ago

UPDATE 3-US signals crackdown on compounded weight-loss drugs; Hims shares tumble

Reuters · 8h ago

CVS pharmacies accepting TrumpRx discount cards

Seeking Alpha · 8h ago

Hims & Hers stock closes at one-year low amid battle over compounded Wegovy pill

MarketWatch · 9h ago

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers

Barron‘s · 9h ago

Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore

The Motley Fool · 10h ago

What's Going On With Novo Nordisk Stock On Friday?

Benzinga · 11h ago

Novo Nordisk: The Selloff Is A Blessing In Disguise

Seeking Alpha · 12h ago

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More

Barron‘s · 12h ago

Market Voices: Novo Nordisk's Super Bowl ad, orbiting data centers

Seeking Alpha · 12h ago

Why Shares of Novo Nordisk Stock Collapsed This Week

The Motley Fool · 13h ago

Novo Nordisk’s CagriSema vs. Tirzepatide: A Key Obesity Trial Reaches Completion

TipRanks · 13h ago

UK regulator warns of rare vision loss risk with Novo's Ozempic, Wegovy

Seeking Alpha · 14h ago

Why Did AMD, Uber, and Novo Nordisk Stock Crash This Week?

NASDAQ · 14h ago

Eli Lilly Stock Rebounds After FDA Says It Will Crackdown on Weight-Loss Drug Copies

TipRanks · 14h ago

Strategy Posts Upbeat Q4 Results, Joins SunOpta, BILL Holdings, Mitek Systems And Other Big Stocks Moving Higher On Friday

Benzinga · 15h ago

Webull provides a variety of real-time NVO stock news. You can receive the latest news about Novo-Nordisk A/S through multiple platforms. This information may help you make smarter investment decisions.

About NVO

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.